A trial carried out through the NHS and the University of Oxford found that 13 percent fewer severely ill patients died of Covid-19 when treated with Baricitinib compared to existing treatment options. Typically used to treat arthritis to reduce pain and inflammation, the NHS said Baricitinib can now be given to hospitalized Covid patients in … Read more
WELLINGTON, Dec. 6 (Xinhua) — New Zealand has secured supplies of another medicine to treat COVID-19, Health Minister Andrew Little said on Monday. In October, New Zealand was one of the first countries in the world to make an advance purchase of a promising new antiviral drug, molnupiravir, Little said in a statement. The national … Read more
Ministry of National Health Services, Regulations, and Coordination has suggested that the Baricitinib or Tofacitinib are appropriate alternative drugs to Tocilizumab to control the mortality rate among COVID-19 patients. As per the latest guidelines issued by the ministry, both drugs belong to the same class of anti-inflammatory drugs like the Janus kinase (JAK) Inhibitors and … Read more
